Press release
In-Depth Analysis of the Shingrix Zostavax Market: Growth Opportunities, Key Trends, and Forecast 2025-2034
Shingrix Zostavax
The Shingrix (Zostavax) market is also set to grow, driven by the increasing adoption of vaccination globally. Growing awareness of the effectiveness of vaccination in preventing diseases, combined with public health initiatives and improved healthcare infrastructure, is boosting vaccination rates. Shingrix, which protects against shingles, is particularly important for adults over 50, reducing the risk of shingles recurrence and post-herpetic neuralgia. In 2023, a report from the Journal of the American Medical Association (JAMA) showed a 46% increase in shingles vaccinations following the implementation of Medicare coverage policies, which is expected to propel the Shingrix market.
Get Your Shingrix Zostavax Market Report Here:
https://www.thebusinessresearchcompany.com/report/shingrix-zostavax-global-market-report
What Is the projected market size and growth rate for the shingrix zostavax market?
The shingrix (zostavax) market size has shown XX (HCAGR) in recent years. It will increase from $XX million in 2024 to $XX million in 2025, with a compound annual growth rate (CAGR) of XX%. This growth is driven by the rising adoption of vaccines, a higher demand for educational campaigns, increased emphasis on preventive healthcare, better patient education and advocacy, and expanded insurance coverage for immunization.
The Shingrix (Zostavax) market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the rising geriatric population, increasing incidence of herpes zoster, rising incidence of chickenpox, increasing disease prevalence, and growing awareness about shingles and its complications. Major trends in the forecast period include innovative recombinant vaccines, advancements in vaccine development, a shift towards disease prevention over treatment, AI-powered vaccine research and development, and advanced biomarker identification for shingles susceptibility.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20264&type=smp
What new trends are reshaping the shingrix zostavax market and its opportunities?
One primary progression in the shingrix (zostavax) market is the innovation of new products. These focus on augmenting the effectiveness of vaccines and tackling the decreasing immunity in susceptible groups as they age through the creation of non-live, recombinant subunit adjuvanted vaccines. This type of vaccine uses specific protein components from a pathogen, supplemented with an adjuvant to amplify the immune response. An example of this is the September 2024 launch of the Shingrix shingles vaccine by UK-based biopharmaceutical firm, GSK plc. The Recombinant Zoster Vaccine (RZV) is a non-live vaccine that offers as much as 97% efficiency in protecting against shingles and post-herpetic neuralgia. Aiming at adults who are 50 years old or over and those who are immunocompromised and aged 18 or over, the vaccine is administered in two injections into the muscle tissue. The ZOE-50 study demonstrated that RZV's an efficacy rate of up to 97% in adults aged 50 and older over a three-year period, with recent evidence suggesting the maintained efficiency at over 80% for 6-10 years following vaccination.
What major market segments define the scope and growth of the shingrix zostavax market?
The shingrix (zostavax) market covered in this report is segmented -
1) By Formulation: Recombinant Vaccine (Shingrix); Live Attenuated Vaccine (Zostavax)
2) By Indication: Shingles Prevention; Post-Herpetic Neuralgia
3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20264
Which region dominates the shingrix zostavax market?
North America was the largest region in the shingrix (zostavax) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the shingrix (zostavax) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which key market leaders are driving the shingrix zostavax industry growth?
Major companies operating in the shingrix (zostavax) market are GSK plc
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20264&type=smp
What Is Covered In The Shingrix Zostavax Global Market Report?
•Market Size Forecast: Examine the shingrix zostavax market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the shingrix zostavax market for a structured understanding.
•Key Players Overview: Analyze major players in the shingrix zostavax market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the shingrix zostavax market.
•Segment Contributions: Evaluate how different segments drive overall growth in the shingrix zostavax market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the shingrix zostavax market.
•Industry Challenges: Identify potential risks and obstacles affecting the shingrix zostavax market.
•Competitive Landscape: Review strategic developments in the shingrix zostavax market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release In-Depth Analysis of the Shingrix Zostavax Market: Growth Opportunities, Key Trends, and Forecast 2025-2034 here
News-ID: 3944294 • Views: …
More Releases from The Business Research Company
Death Care Services Market Demonstrates Long-Term Growth Potential At 7.9% CAGR
The death care services market is on track for significant expansion, reflecting changing consumer preferences and evolving industry practices. With growing interest in personalized and eco-friendly options, the sector is experiencing notable transformation. Let's explore the market size projections, key players, emerging trends, and segmentation to understand the future direction of this important industry.
Projected Growth and Market Size of the Death Care Services Industry
The death care services market…
Cyanoacrylate Adhesives Market Outlook Signals Expansion To $2.1 Billion Through …
The cyanoacrylate adhesives market is set for significant expansion over the coming years, driven by increasing demand for high-performance bonding solutions across various industries. This segment is evolving rapidly due to technological advancements and growing adoption in precision assembly and lightweight jointing applications. Let's explore the market size projections, key players, emerging trends, and segmentation details shaping this dynamic industry.
Long-Term Outlook for the Cyanoacrylate Adhesives Market Size Through 2030 …
Crowdfunding Market Report 2026 Market Outlook Supported By A Forecast 17.1% CAG …
The crowdfunding sector is gaining significant traction as more startups and investors embrace alternative financing methods. With the rise of innovative funding platforms and increasing regulatory support, this market is set for remarkable growth in the coming years. Here's a detailed overview of the market's size, key players, emerging trends, and segment breakdown.
Projected Market Value and Growth Trajectory of the Crowdfunding Market
The crowdfunding market is anticipated to expand…
Credentials Verification Organization (CVO) Services Market Insights Highlight S …
The credentials verification organization (CVO) services sector is on the cusp of remarkable expansion, driven by technological advancements and evolving market needs. As organizations increasingly prioritize secure and efficient verification methods, this industry offers promising growth prospects. Here's an in-depth look at the market size, key players, emerging trends, and segment analysis shaping the future of CVO services.
Projected Market Value Surge in Credentials Verification Organization (CVO) Services
The credentials…
More Releases for Shingrix
Leading Companies Enhancing Their Presence in the Shingrix (Zostavax) Market
The shingles vaccine market is witnessing significant developments as efforts to improve adult vaccination rates and preventive healthcare gain momentum worldwide. With advances in vaccine technology and expanding immunization programs, this industry is poised for substantial growth in the coming years. Let's explore the market size projections, leading companies, influential trends, and segmentation within the Shingrix (Zostavax) sector.
Forecasted Market Size and Growth Drivers in the Shingrix (Zostavax) Industry
The…
Shingles Vaccines Market (2026-2033) | Recombinant Vaccines, Adult Vaccines, Shi …
DataM Intelligence has released a new research report titled "Shingles Vaccines Market Size 2026" The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms…
Shingrix (Zostavax) Market Forecast 2025-2034: Comprehensive Analysis And Growth …
"We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Projected Growth of the Shingrix (Zostavax) Market?
In the past few years, the Shingrix (Zostavax) market has seen a growth of XX (HCAGR). The market, which was worth $XX million in 2024, is projected to further grow to $XX million in 2025, implying a compound annual growth rate (CAGR)…
In-Depth Analysis of the Shingrix (Zostavax) Market: Growth Opportunities, Key T …
What Are the Projected Growth and Market Size Trends for the Shingrix (Zostavax) Market?
The market size for shingrix (zostavax) has seen an increase of $XX (CAGR) in the latest years. The market is expected to surge from $XX million in 2024 to $XX million in 2025, indicating a compound annual growth rate (CAGR) of $XX%. The growth seen in the previous period is due to factors such as enhanced vaccine…
Shingles Vaccine Market Demand Will Reach a Value of USD 6.02 Billion by the Yea …
Anticipated Growth in Revenue:
Shingles Vaccine Market was valued at USD 3.06 Billion in 2022, and it is expected to reach USD 6.02 Billion by 2029, exhibiting a CAGR of 10.1 % during the forecast period (2023-2029)
Shingles Vaccine Market Overview:
The Shingles Vaccine Market is witnessing significant growth due to the increasing awareness of the severe complications associated with shingles, such as postherpetic neuralgia (PHN). Shingrix, a recombinant zoster vaccine, has become…
Shingles Vaccine Market is expected to See Huge Growth by 2023-2030 with Top Pla …
Description:
The Zostavax vaccine is a live attenuated vaccine that contains a weakened form of the herpes zoster virus, which causes shingles. The vaccine works by stimulating the body's immune system to produce a protective response against the virus, thereby reducing the risk of developing shingles. The effectiveness of the Zostavax vaccine varies depending on the age group. According to clinical trials, the vaccine was found to be 64% effective in…
